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Abstract
Gene transcription is constrained by the nucleosomal nature of chromosomal DNA. This nucleosomal barrier is modulated
by FACT, a conserved histone-binding heterodimer. FACT mediates transcription-linked nucleosome disassembly and also
nucleosome reassembly in the wake of the RNA polymerase II transcription complex, and in this way maintains the
repression of ‘cryptic’ promoters found within some genes. Here we focus on a novel mutant version of the yeast FACT
subunit Spt16 that supplies essential Spt16 activities but impairs transcription-linked nucleosome reassembly in dominant
fashion. This Spt16 mutant protein also has genetic effects that are recessive, which we used to show that certain Spt16
activities collaborate with histone acetylation and the activities of a Bur-kinase/Spt4–Spt5/Paf1C pathway that facilitate
transcription elongation. These collaborating activities were opposed by the actions of Rpd3S, a histone deacetylase that
restores a repressive chromatin environment in a transcription-linked manner. Spt16 activity paralleling that of HirC, a co-
repressor of histone gene expression, was also found to be opposed by Rpd3S. Our findings suggest that Spt16, the Bur/
Spt4–Spt5/Paf1C pathway, and normal histone abundance and/or stoichiometry, in mutually cooperative fashion, facilitate
nucleosome disassembly during transcription elongation. The recessive nature of these effects of the mutant Spt16 protein
on transcription-linked nucleosome disassembly, contrasted to its dominant negative effect on transcription-linked
nucleosome reassembly, indicate that mutant FACT harbouring the mutant Spt16 protein competes poorly with normal
FACT at the stage of transcription-linked nucleosome disassembly, but effectively with normal FACT for transcription-linked
nucleosome reassembly. This functional difference is consistent with the idea that FACT association with the transcription
elongation complex depends on nucleosome disassembly, and that the same FACT molecule that associates with an
elongation complex through nucleosome disassembly is retained for reassembly of the same nucleosome.
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Introduction
The packaging of DNA into chromatin, mainly in the context of
nucleosomes, restricts access to the DNA template. Several
proteins or protein complexes regulate access to DNA for
transcription [1,2]. Among these is a nuclear heterodimer named
FACT(facilitates chromatin transcription), a histone chaperone
whose subunits are encoded throughout the eukaryotic lineage.
While FACT has recently been implicated in the transcription of
rRNA genes by RNA polymerase I and small-RNA genes by RNA
polymerase III [3], more is known about the involvement of
FACT in facilitating transcription of protein-coding genes by
RNAPII and its accessory proteins [4].
FACT has several activities during transcription. Most notably,
FACT is involved in diminishing the nucleosomal barrier to
transcription that is encountered by RNAPII, and in this way
facilitates transcription elongation. This outcome is achieved in
part by the destabilization of normal nucleosomal structure, which
can involve the reorganization of normal histone protein
interactions and/or the displacement of histones [2]. FACT can
destabilize a nucleosome during in vitro transcription by dissoci-
ating one histone H2A–H2B heterodimer from the rest of the
nucleosome [5,6]. FACT can also reorganize nucleosomal
structure without H2A–H2B displacement [7]. FACT and/or its
subunits bind intact nucleosomes, the H2A–H2B dimer, and the
histone (H3–H4)2 tetramer [5,8–10], and genetic studies of yeast
FACT indicate a role for FACT in nucleosome disassembly or
reorganization through modulation of H2A–H2B:(H3–H4)2
interactions [11,12]. Furthermore, the Spt16 subunit of FACT
can be mutated to relieve the transcriptional effects of a histone
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[13,14]. FACT co-purifies with transcription complexes and
localizes to transcribed regions, suggesting that FACT travels
with RNAPII to facilitate access to nucleosomal DNA during
transcription elongation [15–18].
FACT also participates in the nucleosome reassembly that takes
place in the wake of the transcription complex, as evidenced by the
transcription-dependent loss of histones from transcribed regions
in yeast cells mutant for FACT subunit Spt16 [19,20]. Another
readout of transcription-linked nucleosome reassembly is the
maintenance of chromatin repression of transcription from
‘cryptic’ promoter sequences that exist within some yeast genes
[21]. Sequences internal to many transcribed regions have the
potential to be sites of transcription initiation, but are repressed by
normal nucleosome structure. The maintenance of this repression
during transcription depends on the efficient reestablishment of
nucleosome structure after the passage of RNAPII. FACT
mutations can allow transcription initiation at cryptic promoter
sites [16,21–24]; indeed, a genome-wide survey found that over
15% of yeast genes harbor cryptic promoters whose repression
depends on FACT [25]. FACT activity, through its ability to
mediate the transcription-linked restoration of nucleosome
structure, is thus necessary for the fidelity of transcription
initiation.
FACT has effects on transcription initiation that are more
direct. The yeast FACT subunit Spt16 physically interacts with the
general transcription factor TFIIE, and shows genetic interactions
with the general transcription initiation factor TFIIA and with
TATA-binding protein TBP, which binds TFIIA and promoter
DNA for transcription initiation [26,27]. Mutating the Spt16
subunit of FACT can decrease TBP binding to promoters in vivo,
while in vitro assays show that FACT facilitates the cooperative
binding of TBP and TFIIA to promoter sequences that are in a
nucleosomal configuration [16,27,28]. This effect of FACT on
TBP binding reflects several activities, including chromatin
disassembly at promoters [29–31], which may in some cases
reflect the nucleosome dynamics accompanying regulatory
transcription across a promoter [32]. FACT subunits also have
physical and functional interactions with gene-specific transcrip-
tion activators [29,31,33–35].
Significant advances in understanding Spt16 functions, and thus
most likely FACT functions, have been made through the study of
spt16 mutations that were identified because they cause temper-
ature sensitivity for yeast cell proliferation [8]. Such mutational
consequences need not be specific to transcription: FACT and/or
its subunits are also implicated in DNA replication and
heterochromatin function [36–39]. Moreover, many tempera-
ture-sensitive spt16 mutations destabilize the mutant Spt16
protein, making it difficult to distinguish inadequate but normal
Spt16 function from mutationally impaired function [40,41]. To
avoid potentially confounding effects due to protein stability, we
decided to study the functional relationships of Spt16 by focusing
on mutant alleles of the yeast SPT16 gene that affect function in a
dominant manner; our reasoning was that a mutant Spt16 protein
with a dominant effect would be expected to be relatively stable
[42]. The spt16-E857K and spt16-E763G substitution mutations
were identified through the impaired control over inappropriate
transcription initiation that they cause as a consequence of
defective nucleosome reassembly in the wake of transcribing
RNAPII: each of these mutations, in dominant (or co-dominant)
fashion, activates functional transcription from cryptic promoters
within certain reporter genes [42]. Nonetheless, the Spt16-E857K
and Spt16-E763G mutant proteins also supply all essential
activities of Spt16 [42]. These observations, coupled with the
knowledge that the FACT heterodimer contains a single Spt16
subunit [43,44], indicates that each mutant version of FACT
retains important interactions, but is deficient in interactions that
facilitate efficient nucleosome reassembly.
The spt16-E857K mutant allele was used here in a genetic study
to explore functional interactions with several components that
influence transcription elongation. These experiments indicated
that Spt16, and therefore FACT, has activities that parallel those
of other conserved factors that facilitate transcription elongation,
including the elongation factors Bur1–Bur2, Spt4–Spt5 and
Paf1C, and the HirC corepressor of histone gene expression.
Furthermore, several deleterious genetic interactions involving
spt16-E857K were alleviated by preventing the Rpd3S-mediated
deacetylation of histones that normally occurs during transcription
elongation. These findings suggest not only that Spt16 carries out
chromatin-related activities during transcription elongation, but
also that these activities overlap functionally those of a Bur kinase/
Spt4–Spt5/Paf1C pathway.
Results
Novel dominant Spt16 mutants relieve repression of
‘cryptic’ promoters
The transcription process involves the disassembly of nucleo-
somes for access to DNA, followed by the reassembly of
nucleosomes in the wake of the transcription-elongation complex.
Impaired transcription-linked nucleosome reassembly can allow
aberrant transcription initiation from sequences (‘cryptic promot-
ers’) within the bodies of certain genes. In an earlier study we
described the identification and partial characterization of novel
mutant alleles of the SPT16 gene that, in dominant fashion, allow
effective transcription from cryptic promoters in certain reporter
genes [42]. We report here that this dominant phenotype is also
caused by several more spt16 mutant alleles (Table 1, which also
lists the mutant alleles described previously).
A useful reporter of chromatin status is the prGAL1-FLO8-HIS3
gene, which was constructed to have functional transcription of its
HIS3 ORF possible only through transcription initiation at a
cryptic internal promoter, within FLO8 ORF sequences, that is
normally repressed by chromatin (nucleosome) structure [25]. The
controllable GAL1 promoter driving this FLO8-HIS3 reporter gene
allows evaluation of the requirement for transcription across the
cryptic internal promoter from the upstream GAL1 promoter, as
expected for a situation of promoter activation through faulty
nucleosome reassembly in the wake of RNAPII passage. All
plasmid-borne spt16 mutant alleles listed in Table 1 activated the
prGAL1-FLO8-HIS3 reporter gene in dominant fashion, in a
manner dependent on GAL1 promoter activity. Similarly, in cells
lacking the chromosomal SPT16 gene the novel spt16 mutant
alleles that supply essential function activated this reporter gene in
a manner dependent on GAL1 promoter activity (Table 1). Thus
all of the novel spt16 mutant alleles have effects consistent with
inefficient transcription-linked nucleosome reassembly.
As indicated in Table 1, we found that several mutations
selected by transcription-linked nucleosome-reassembly effects also
display other known phenotypes of spt16 mutations [8]. Thus other
biological activities of Spt16 may also be compromised by some of
these mutations, including spt16-E857K.
A screen for deleterious genetic interactions with
spt16-E857K identified bur2
We used the spt16-E857K mutant allele that interferes with
transcription-linked nucleosome reassembly in a screen for
deleterious genetic interactions, indicative of a common down-
FACT Involvement in Yeast Transcription Elongation
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[45]. Mutations that are deleterious in combination with spt16-
E857K can show how Spt16 activity relates to the activities of other
factors.
Through a plasmid-loss procedure and two-color discrimination
system for screening yeast colonies [46,47] we identified five
derivatives that failed to grow when relying on the Spt16-E857K
mutant protein, but grew well if the cells also contained normal
Spt16. These derivatives therefore harbor mutations that have
deleterious interactions with spt16-E857K effects that are recessive.
For one derivative from the screen, lethality was alleviated by
genomic plasmids and subclones containing the BUR2 gene,
suggesting the presence of a bur2 mutation (Figure 1A). Indeed,
this BUR2 locus (bur2-fs1) contains an extra G residue (coding
strand) following ORF position 253, causing an R85K substitution
and a frameshift that brings into register a stop codon, resulting in
a truncated protein. This Bur2 fragment is unlikely to be
functional: SPT16 bur2-fs1 mutant cells have a slow-growth
phenotype analogous to that of bur2D cells (Figure 1A). Thus
Spt16 and Bur2 have a common downstream function.
spt16-E857K interacts genetically with both subunits of
Bur kinase
Bur2 is involved in transcription elongation as the regulatory
subunit of the Bur1–Bur2 cyclin-dependent kinase; Bur1 is the
catalytic subunit. Deletion of BUR2 decreases Bur1 activity;
conversely, many bur2D effects are alleviated by increased BUR1
expression [48]. We found that the deleterious genetic interaction
between bur2 and spt16-E857K (in cells with a chromosomal BUR1
gene) was also relieved by increased Bur1 expression from a low-
copy BUR1 plasmid, although not by several partially functional
Bur1 mutants [49] expressed in the same way (Figure 1B). This
finding suggests that the lethality of spt16-E857K bur2 double-
mutant cells is due to inadequate Bur kinase activity.
Using cells with normal Bur2 function, we tested several bur1
mutations [49] for genetic interactions with spt16-E857K, using a
plasmid-shuffling approach. In combination with spt16-E857K
none of the bur1 mutations was lethal, but growth was impaired by
two mutations with decreased Bur kinase activity: the temperature-
sensitive mutant allele bur1-23 and bur1-T240A, mutated to
eliminate an activating phosphorylation site (Figure 1C). These
observations, along with our bur2 findings, suggest that the spt16-
E857K mutation compromises a specific Spt16 activity, so that
phosphorylation by Bur kinase becomes essential; that is, Spt16
and phosphorylation by Bur kinase have a common downstream
effect. Based on these findings we decided to take an in vivo genetic
approach to understand the functional relationship between Spt16
and the transcription elongation factor Bur kinase.
No genetic interaction between spt16-E857K and CTDK-1,
an RNAPII CTD kinase
One Bur kinase substrate is RNAPII. Bur kinase phosphorylates
the largest subunit of RNAPII on serine-2 of its C-terminal-
domain (CTD) repeat to stimulate transcription elongation
[50,51]. In this activity, Bur kinase may be a yeast ortholog of
mammalian P-TEFb. Yeast cells have another putative P-TEFb
ortholog, CTDK-1, which also phosphorylates Ser-2 of the CTD
repeat [52]. We found that eliminating the CTDK-1 catalytic
subunit by a ctk1D gene deletion failed to affect the growth of
spt16-E857K cells (data not shown). This observation is consistent
with other work showing that CTDK-1 and Bur kinase have
distinct functions: they are recruited to the transcription complex
through distinct sequential mechanisms, and phosphorylate
distinct spectra of substrates in addition to the RNAPII CTD
Table 1. spt16 Mutant alleles that activate cryptic promoters in dominant fashion (1).



















SPT16 — ++ + 2 ++
spt16-E857K E857K + nd (4) ++ ++ /2
spt16-E763G E763G + nd ++ ++
spt16-312 E763G, R784G, S819P ++ + + 2 +
spt16-319 L804P, L946S, E1004G ++ + + 22
spt16-L804P L804P ++ + + 22
spt16-216 (3) T677M, R686G, K692E ++ 2 na (5) na na
spt16-Q682R,D770G Q682R, D770G + nd ++ ++
spt16-Q682R,T772P Q682R, T772P + nd ++ +nd
spt16-D766G D766G + nd ++ +2
spt16-E794V E794V ++ 2 na na na
spt16-D884G D884G nd ++ + + 2
spt16-V902F,N927D V902F, N927D ++ 2 na na na
spt16-F944V,F945S (3) F944V, F945S ++ 2 na na na
(1)All mutant alleles listed here, on low-copy plasmids, activate the reporter genes his4-912d, lys2-128d,a n dGAL1pr-FLO8-HIS3 at 30uCi nSPT16 cells (strains AW11-9a and
FY2393). Some data for spt16-E857K, spt16-E763G, spt16-312,a n dspt16-319 are from [42].
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kinase may therefore implicate a phosphorylation substrate other
than the RNAPII CTD.
spt16-E857K does not impair the Rad6–COMPASS
pathway
Another target of Bur kinase is Rad6. Phosphorylation of Rad6
promotes histone H2B ubiquitination and the consequent
recruitment of the histone methyltransferase COMPASS and
trimethylation of histone H3 on lysine 4 (K4), a hallmark of
transcribed regions [54,55]. Our western blots showed no
difference in H3K4 trimethylation levels between cells containing
normal or mutant Spt16, indicating that the spt16-E857K mutation
does not impair Rad6 or COMPASS function (Figure 2A).
We investigated the possibility that the spt16-E857K mutation
might impair an Spt16 activity that overlaps that of H2B
ubiquitination or H3K4 methylation by analyzing double-mutant
derivatives created by standard genetic procedures. The rad6D
mutation itself causes both cold sensitivity and temperature
sensitivity [56] and all of our rad6D single-mutant segregants
exhibited sensitivity to high and low growth temperatures, to the
same degree as the double-mutant derivatives (Figure 2B). There
was no significant genetic interaction between spt16-E857K and
rad6D.
The lack of genetic interactions in spt16-E857K rad6D cells was
mirrored by the lack of genetic interactions between spt16-E857K
and the set1D, swd1D, and swd3D deletions eliminating components
of COMPASS (Figure 2C, D). The set1D deletion eliminates the
methyltransferase subunit, and cells lacking Swd1 or Swd3 do not
methylate H3K4 [57]. This finding that spt16-E857K failed to
impair the growth of COMPASS mutants contrasts with the
strong genetic interaction between set1D and spt16-11, a mutant
allele encoding a temperature-sensitive Spt16 mutant protein [28].
Evidently the Spt16-E857K mutant protein retains the Spt16
function that overlaps that of COMPASS, and is thus selectively
impaired for function. The genetic interactions between spt16-
E857K and Bur-kinase mutations are due to a consequence of Bur
kinase activity other than Rad6-mediated H2B ubiquitination or
H3K4 methylation.
spt16-E857K impairs the growth of cells mutant for the
Spt4–Spt5 complex
Another target of Bur kinase is the Spt4–Spt5 complex (termed
DSIF [DRB-sensitivity inducing factor] in metazoans), which is
involved in transcription elongation and counteracts the tendency
for nucleosomes to cause transcription arrest [58]. The Spt5
protein contains tandem repeats in its C terminus that are
phosphorylated by Bur kinase [51,59]. We found that the spt5-4
Figure 1. Cells relying of Spt16-E857K need significant Bur kinase activity. (A) The inviability of spt16-E857K bur2-fs1 double-mutant cells is
complemented by the SPT16 or BUR2 gene. Using a plasmid-shuffling approach, spt16D bur2-fs1 cells (strain AFO416), deleted for the chromosomal
SPT16 ORF but kept alive by spt16-E857K TRP1 and SPT16 URA3 plasmids, were transformed with a LEU2 plasmid carrying the indicated gene, and
derivatives that failed to inherit the SPT16 URA3 plasmid were selected on 5-FOA medium. Only cells harbouring a LEU2-based plasmid that alleviates
the spt16-E857K bur2-fs1 synthetic lethality are able to grow on 5-FOA medium. (B) Increased Bur1 activity suppresses the inviability of spt16-E857K
bur2-fs1 double-mutant cells. Cells of strain AFO416 were transformed with BUR1 LEU2 or bur1 LEU2 plasmids before 5-FOA selection for cells that had
failed to inherit the SPT16 URA3 plasmid. (C) spt16-E857K mutant cells need significant Bur1 activity for growth. Plasmid-shuffle procedures were used
to create derivatives of spt16D bur1D double-mutant cells (strain bur1D68D3C) that carry BUR1 (or bur1) LEU2 plasmids, and SPT16 (or spt16) TRP1
plasmids. These derivatives (strains JS312 through JS329) were then grown to stationary phase in liquid culture and normalized for cell concentration,
and 10-fold serial dilutions were spotted on selective solid medium for growth at the indicated temperatures.
doi:10.1371/journal.pone.0025644.g001
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with spt16-E857K, suggesting a common function (Figure 3A). We
also found genetic interactions between spt16-E857K and an spt4D
deletion eliminating the binding partner of Spt5 (Figure 3A). Thus
Spt16 has a function in common with Spt4–Spt5, and this function
is impaired by the spt16-E857K mutation.
Genetic interactions between spt16-E857K and mutations
affecting Paf1C
A downstream effector of Spt4–Spt5 is the multi-subunit
complex Paf1C, which is involved in the elongation stages of
transcription, associates with FACT, Spt4–Spt5, and RNAPII,
and localizes throughout the coding regions of genes. Bur kinase,
Spt5 phosphorylation, and the Spt4 protein are important for this
Paf1C localization and for Paf1C association with RNAPII,
suggesting that Spt4–Spt5 is a platform for Paf1C recruitment
[62]. Paf1C facilitates nucleosome disassembly upon the induction
of transcription [63].
We saw impaired growth for spt16-E857K cells lacking Paf1C
components (Figure 3B). The most severe impairments were seen
for spt16-E857K ctr9D double-mutant cells, which failed to grow
(Figure 3B), and spt16-E857K paf1D double-mutant cells, which
grew poorly even at 30uC (Figure 3B). Moderate growth
impairments were seen for both spt16-E857K cdc73D and spt16-
E857K leo1D double-mutant cells (Figure 3B). An analogous
spectrum of effects has been reported for genetic interactions
between Paf1C gene deletions and spt16-197, a point mutation
that destabilizes the mutant Spt16 protein in temperature-
dependent fashion [24,64]. In general, Paf1C has complex genetic
interactions, and the phenotypes of ctr9D and paf1D cells are more
severe than those of cdc73D or leo1D cells [65].
Set2 and Rpd3S intensify the spt16-E857K bur2D genetic
interaction
The growth of bur1D cells is markedly improved by several gene
deletions (set2D, rpd3D, sin3D, eaf3D and rco1D) eliminating
members of a histone-modification pathway distinct from the
COMPASS pathway described above [66,67]. In this pathway,
the Set2 protein is recruited to transcriptionally engaged RNAP II
phosphorylated on serine 2 of its CTD repeats; Set2 then
methylates lysine 36 of histone H3 (H3K36) on nucleosomes that
are reassembled after RNAPII transit. H3K36 dimethylation
allows nucleosome binding by the Rpd3S complex (comprising
Rpd3, Sin3, Eaf3, and Rco1), which deacetylates nucleosomal
histones to restore a transcriptionally repressive chromatin
environment [68].
The observations that Rpd3S deacetylation activity presents a
significant problem for cells with impaired Bur kinase suggest that
Bur kinase fosters transcription in part by counteracting the effects
of a repressive chromatin environment. The spt16-E857K bur2D
synthetic lethality reported here could therefore reflect different
but complementary roles played by FACT and Bur kinase in
overcoming the repressive effects of deacetylated histones resulting
from Rpd3S activity. This hypothesis was tested genetically.
To ensure that deletions of genes involved in Set2-mediated
H3K36 methylation effects do not themselves have deleterious
genetic interactions with spt16-E857K, we assessed double-mutant
cells harboring spt16-E857K and either set2D, sin3D, eaf3D,o r
rco1D. In each case, the double mutant grew as well as each single
mutant (data not shown). Standard genetic procedures were then
used to determine whether Set2-mediated H3K36 methylation is
inhibitory in cells mutant for both Bur kinase and Spt16. We
found that, in contrast to the lethality of spt16-E857K bur2D
Figure 2. Rad6–COMPASS impairment is not responsible for the Bur-kinase genetic interaction with spt16-E857K. (A) Neither spt16-
E857K nor spt16-E763G affect H3K4 trimethylation. Whole cell extracts were prepared from Y2454-WT68, -E857K, and -E763G cells, and equal amounts
of extract, as determined by Bradford assays, were resolved electrophoretically and immunoblotted with antibodies against total H3 (top) and H3
trimethylated at K4 (bottom). (B) No genetic interactions between spt16-E857K and rad6D. Haploid genetic segregants from diploid cells made
heterozygous for spt16-E857K and rad6D by RAD6 gene replacement were sporulated and tetrad analysis was carried out. Representative segregants
were grown to stationary phase in liquid culture and normalized for cell concentration, and 10-fold serial dilutions were spotted on rich medium for
further growth at the indicated temperatures. (C) No genetic interactions between spt16-E857K and the Swd1 or Swd3 subunits of COMPASS. Diploid
cells (Y2454-E857K6BY4741 orfD) heterozygous for spt16-E857K and swd1D or swd3D were sporulated, and the spores from complete tetrads
(arranged vertically) were germinated and grown on rich solid medium. Double-mutant segregants containing spt16-E857K and either swd1D or
swd3D are circled. (D) No genetic interactions between spt16-E857K and the Set1 catalytic subunit of COMPASS. Diploid cells (Y2454-E857K6BY4741
set1D) heterozygous for spt16-E857K and set1D were sporulated and tetrad analysis was carried out. Representative segregants were grown to
stationary phase and normalized for cell concentration, and 10-fold serial dilutions were spotted on rich solid medium for further growth at the
indicated temperatures.
doi:10.1371/journal.pone.0025644.g002
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segregants formed colonies, showing that Set2 is indeed inhibitory
in spt16-E857K cells with impaired Bur-kinase activity (Figure 4A).
Spt16 and Bur kinase therefore carry out a common function that
is antagonized by the Set2 histone methyltransferase.
Yeast cells have two H3K36-specific demethylases that
counteract Set2 methylation activity: Rph1, which demethylates
trimethylated K36 and to a lesser extent dimethylated K36, and
Jhd1, which demethylates di- and mono-methylated K36 [69,70].
Increased expression of either Rph1 or Jhd1, and the resultant
decreases in H3K36 methylation [69,70], can bypass the essential
requirement for Bur1 [69], observations consistent with the genetic
findings reported here. We tested the converse situation, whether
increased levels of H3K36 methylation due to jhd1D or rph1D
deletion mutations [69,70] would impair the growth of spt16-
E857K mutant cells. However, double-mutant cells harbouring
spt16-E857K and either jhd1D or rph1D grew as proficiently as the
single-mutant cells (Figure 4B). Increased levels of H3K36
methylation are not inhibitory in spt16-E857K mutant cells.
The status of Rpd3, the deacetylase subunit of Rpd3S, has both
positive and negative effects in cells harboring spt16 mutant alleles
different than those used here [8,11]; interpretation is difficult,
however, for Rpd3 is also part of another histone deacetylase
complex [67,71]. A subunit specific to Rpd3S is Rco1 [67,71]. In
cells lacking Rco1, the Eaf3 subunit fails to associate with the
remaining Rpd3S subunits, thus preventing formation of func-
tional Rpd3S [71]. An rco1D gene deletion alleviated the synthetic
lethality between spt16-E857K and bur2D (Figure 4C), suggesting
that histone deacetylation makes chromatin difficult for spt16-
E857K bur2D double-mutant cells to transcribe.
Unlike the positive effects on bur2D cells seen for an eaf3D
deletion [67], the rco1D deletion did not improve the slow growth
of bur2D cells (Figure 4C); spt16-E857K rco1D bur2D triple-mutant
cells also exhibited slow growth, much like that of a bur2D cells
(Figure 4C). These observations suggest that the slow growth of
bur2D cells results from a different impairment than that exposed
by Rpd3S histone deacetylation.
Rpd3S intensifies spt16-E857K genetic interactions with
Paf1C mutations
The bur2D findings described above suggest that the Rpd3S
histone deacetylase may also be inhibitory in spt16-E857K cells
mutated for Bur-kinase effectors. We found that neither spt16-
E857K spt5-4 rco1D nor spt16-E857K spt5-194 rco1D triple mutants
grew better at high temperatures than their respective spt16-E857K
spt5 double mutants (Figure 3A). In contrast, rco1D did relieve the
deleterious genetic interactions of spt16-E857K with Paf1C
mutations (Figure 4D). This rco1D effect is incomplete, however,
for the growth of the triple mutants remained impaired at
temperatures permissive for the single mutants, suggesting that
only a subset of Paf1C activities is opposed by Rpd3S-mediated
histone deacetylation (data not shown). These genetic interactions
suggest that Rpd3S histone deacetylation makes Spt16 activity
Figure 3. The spt16-E857 mutation increases reliance on Spt4–
Spt5 and Paf1C. (A) Deleterious genetic interactions between spt16-
E857K and mutations affecting Spt4–Spt5. Cells of strain JS338 were
crossed with those of strains JS334, FY362, and FY1668, the resulting
diploids were sporulated, and tetrad analysis was carried out.
Representative segregants were grown to stationary phase and
normalized for cell concentration, and 10-fold serial dilutions were
spotted on rich solid medium for further growth at the indicated
temperatures. (B) Lethal genetic interaction with the Paf1C component
Ctr9. Y2454-E857K6KY693 diploid cells heterozygous for spt16-E857K
and ctr9D were sporulated, and the spores from complete tetrads
(arranged vertically) were germinated and grown on rich solid medium.
Positions of the spt16-E857K ctr9D double-mutant segregants are
circled. (C) Deleterious genetic interactions with Paf1C components.
Representative segregants of each indicated genotype were grown to
stationary phase and normalized for cell concentration, and 10-fold
serial dilutions were spotted on rich solid medium for further growth at
the indicated temperatures.
doi:10.1371/journal.pone.0025644.g003
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operates inefficiently with deacetylated histones.
Rpd3S intensifies spt16-E857K genetic interactions with
the histone chaperone HirC
The bur2, spt4, and cdc73 (Paf1C) deletion mutations shown here
to have deleterious genetic interactions with spt16-E857K are also
deleterious in combination with mutations inactivating HirC, a
histone chaperone [11,72]. The HirC subunits Hir1 and Hir2 are
structural orthologs of portions of the metazoan HIRA protein
and, like HIRA, facilitate replication-independent histone depo-
sition onto DNA [73,74]. HirC is usually dispensible, but becomes
very important in cells harbouring certain temperature-sensitive
spt16 mutant alleles [11]. Likewise, using the plasmid-loss
procedure described above we found that HirC activity is critical
for cells relying on the Spt16-E857K protein. In one derivative
from our screen the deleterious genetic effects with spt16-E857K
Figure 4. Rpd3S function intensifies deleterious spt16-E857K genetic interactions. (A) H3K36 methylation by Set2 is detrimental in spt16-
E857K bur2D cells. Diploid cells heterozygous for spt16-E857K, bur2D, and set2D were sporulated, the spores from complete tetrads (arranged
vertically) were germinated and grown on rich solid medium. spt16-E857K bur2D set2D triple-mutant segregants are circled, while the positions of
spt16-E857K bur2D double-mutant segregants are marked with squares. (B) No obvious benefit of H3K36 demethylation by Jhd1 or Rph1 in spt16-
E857K cells. Tetrads were dissected for sporulated diploids (Y2454-E857K6BY4741 orfD) heterozygous for spt16-E857K and jhd1D or rph1D. In each
case, double-mutant segregants are circled. (C) Rpd3S activity is detrimental in spt16-E857K bur2D mutant cells. (top) Diploid cells heterozygous for
spt16-E857K, bur2D, and rco1D were sporulated and resulting tetrads were dissected. spt16-E857K bur2D rco1D triple-mutant segregants are circled,
while the positions of spt16-E857K bur2D double-mutant segregants are marked with squares. (bottom) Representative bur2D and bur2D rco1D
segregants were grown to stationary phase in liquid culture and normalized for cell concentration, and 10-fold serial dilutions were spotted on rich
solid medium for growth at the indicated temperatures. (D) Rpd3S activity inhibits spt16-E857K mutant cells lacking normal Paf1C activity. (top)
Diploid calls heterozygous for spt16-E857K, ctr9D, and rco1D were sporulated and resulting tetrads were dissected. spt16-E857K ctr9D rco1D triple-
mutant segregants are circled, while the positions of spt16-E857K ctr9D double-mutant segregants are marked with squares. (bottom) Representative
segregants with the indicated genotypes were grown to stationary phase in liquid culture and normalized for cell concentration, and 10-fold serial
dilutions were spotted on rich solid medium for growth at the indicated temperatures.
doi:10.1371/journal.pone.0025644.g004
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substitution affects the Hir2 HIRA domain, conserved among
HIRA orthologs and thought to be important for protein function.
In another derivative the genetic interaction was due to the
mutation hir1-L760P; this L760P substitution affects the part of
Hir1 involved in Hir2 binding [75], and may therefore weaken the
physical interaction between Hir1 and Hir2. Consistent with this
interpretation, a low-copy HIR2 plasmid alleviated the synthetic
lethality caused by hir1-L760P (data not shown). Our screen also
identified a mutation affecting the HirC subunit Hir3 (data not
shown). HirC mutations cause increased histone gene expression
[76], and we found that increased expression of histones H2A–
H2B from a high-copy plasmid [77] impairs spt16-E857K cells with
normal HirC activity (Figure 5A), suggesting that the deleterious
genetic effects of HirC mutations seen here are at least partially
due to altered histone abundance and/or stoichiometry. Such
histone alterations caused by HirC mutations may well affect
transcription-related nucleosome disassembly, because the growth
impairment of spt16-E857K hir2D cells was relieved by an rco1D
mutation eliminating Rpd3S activity (Figure 5B). A role for HirC
in transcription-linked nucleosome disassembly is also indicated by
other findings [78]. These observations are consistent with the idea
that, in addition to Spt16 (FACT) and Paf1C, histone expression
exerts a third influence on transcription-linked nucleosome
disassembly.
The histone acetyltransferases Gcn5 and Esa1 facilitate
Spt16-E857K activity
The above results suggest that Spt16 helps to overcome the
repressive effects of deacetylated histones that result from Rpd3S
activity. Spt16 may therefore interact with histone acetyltransfer-
ases (HATs) that acetylate the histones deacetylated by Rpd3S
during the previous round of transcription. The HATs SAGA and
NuA4 are known to mediate transcription-linked histone acetyla-
tion [79,80]. We therefore assessed the growth of spt16-E857K cells
harbouring mutations affecting these two HATs and other HATs
implicated in transcription.
Sas3, Elp3 and Gcn5 are the catalytic subunits of HAT
complexes, and deletion of their genes eliminates the HAT activity
of NuA3 (sas3D) [81], Elongator (elp3D) [82] and SAGA, SLIK/
SALSA, and ADA (gcn5D) [83]. Esa1 is the catalytic subunit of the
HAT NuA4; the ESA1 gene is essential, so we used the substitution
mutation esa1-L254P, which enfeebles Esa1 [84,85]. We saw no
significant growth impairment for spt16-E857K in combination
with sas3D, elp3D, gcn5D,o resa1-L254P (data not shown). This is
another indication that spt16-E857K exerts more selective effects
on Spt16 activity than does a temperature-sensitive mutation such
as spt16-11, which has deleterious genetic interactions with the
same HAT mutations [11].
To test the possibility of overlapping HAT functions, we
evaluated triple-mutant cells containing spt16-E857K, esa1-L254P,
and either gcn5D or sas3D (the combination of gcn5D and sas3D is
itself lethal) [86]. The spt16-E857K esa1-L254P sas3D triple
mutants grew as well as the single or double mutants, indicating
a lack of genetic interaction among these mutations (data not
shown). In marked contrast, spt16-E857K esa1-L254P gcn5D triple-
mutant cells grew very poorly, indicating a common functional
role for the affected proteins (Figure 6). A milder genetic
interaction was seen between esa1-L254P and gcn5D in cells with
normal Spt16 function, as previously reported [80]. In each case,
growth was more impaired at higher temperatures. The growth
impairment did not seem to be a consequence of activation of an
S-phase or M-phase checkpoint, for the spt16-E857K esa1-L254P
gcn5D triple-mutant populations failed to accumulate cells with the
large-budded morphology typical of cells with these checkpoints
activated (data not shown). It is therefore likely that the growth
defects of esa1-L254P gcn5D double-mutant and spt16-E857K esa1-
L254P gcn5D triple-mutant cells result from impaired transcription.
Spt16-E857K associates normally with RNA polymerase II,
but poorly with histones
Spt16 exists in complexes with RNAPII and many other
proteins involved in transcription elongation [15,64]. We found
that RNAPII co-purified equally well with Spt16-E857K, Spt16-
E763G, and normal Spt16 proteins (Figure 7A), indicating that
these mutant Spt16 proteins retain normal RNAPII interactions.
Figure 5. Rpd3S is detrimental in spt16-E857K cells with altered
histone expression. (A) Increased expression of histones H2A–H2B
impairs spt16-E857K cells. Cells of strains Y2454 and Y2454-E857K
harboring the high-copy plasmid YEp24-TRT1, which carries the HTA1–
HTB1 histone-gene pair, were grown to stationary phase in liquid
culture and normalized for cell concentration, and 10-fold serial
dilutions were spotted on solid selective medium for growth at the
indicated temperatures. (B) Rpd3S activity inhibits spt16-E857K cells
lacking the histone-gene co-repressor HirC. Diploid cells
(JS3386BY4741 hir2D) heterozygous for spt16-E857K, hir2D, and rco1D
were sporulated, and the resulting tetrads were dissected (spores
arranged vertically). The spt16-E857K hir2D rco1D triple mutant
segregants (white circles) grew significantly better than the spt16-
E857K hir2D RCO1 double-mutant segregants (white squares).
doi:10.1371/journal.pone.0025644.g005
Figure 6. The Esa1 and Gcn5 histone acetyltransferases have
an overlapping activity that benefits spt16-E857K mutant cells.
Haploid spt16 esa1-L254P derivatives, created by several backcrosses of
esa1-L254P (from strain LPY3500) into the Y2454 genetic background,
were crossed with gcn5D mutant cells. Representative segregants with
the indicated genotypes were grown to stationary phase and
normalized for cell concentration, and 10-fold serial dilutions were
spotted on rich solid medium for further growth at the indicated
temperatures.
doi:10.1371/journal.pone.0025644.g006
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the interaction of histone H2B with Spt16-E857K, and Spt16-
E763G, by co-purification (pull-down) assays. Interaction between
Spt16 and histones is likely to be transient, so pull-downs were
carried out over a range of potassium acetate concentrations to
maximize the detection of weak interactions and indicate
interaction strength. H2B co-purified with normal Spt16, Spt16-
E763G, and Spt16-E857K, with substantially more H2B recov-
ered in the 50 mM potassium acetate pull-downs than in the
100 mM or 150 mM pull-downs (Figure 7B). At higher potassium
acetate concentrations less H2B co-purified with the Spt16-E857K
mutant protein than with either Spt16 or Spt16-E763G, indicating
that the interaction between Spt16-E857K and histone H2B is
weak compared to that of normal Spt16 and Spt16-E763G.
Co-purification of histone H2B with Spt16 could be the result of
interactions with H2A–H2B dimers and/or with intact nucleo-
somes. However, no histone H3 was detected in any of the Spt16
pull-downs (Figure 7C). Thus our co-purifications probably
detected Spt16 interaction with free H2A–H2B dimers rather
than with intact nucleosomes. This interpretation is consistent with
the proposed role for Spt16 as a histone chaperone that extracts
one H2A–H2B dimer from a nucleosome to allow passage of the
transcription elongation complex [4]. As a result of its weaker
histone-binding activity, however, Spt16-E857K is unable to
facilitate effective nucleosome reassembly.
Discussion
The histone chaperone FACT is involved in the elongation
stages of RNAPII-mediated gene transcription, facilitating the
dismantling and reassembly of nucleosomes encountered by the
transcription complex [4]. For the Spt16 component of yeast
FACT, several substitution mutations have been identified that
impair transcription-linked nucleosome reassembly but preserve
the essential functions of Spt16, and are thus selective in their
effects (Table 1). We report here that one of these substitution
mutations, spt16-E857K, also compromises an important histone-
related activity for transcription elongation, as indicated by
biochemical and genetic interactions. Co-purification studies
showed that the Spt16-E857K mutant protein, while unaffected
for interaction with RNAPII, is impaired for interaction with
histone H2B, which probably reflects decreased interaction with
the H2A–H2B heterodimer. The spt16-E857K mutation has
deleterious genetic interactions with mutations affecting the
transcription elongation factors Bur kinase, Spt4–Spt5, and Paf1C.
Most of these mutations, like spt16-E857K itself, also impair
transcription-linked nucleosome reassembly as indicated by
cryptic-promoter activity [25,60,64]. In light of the evidence for
functionally distinct classes of cryptic promoters [25], the poor cell
growth of spt16-E57K cells harboring other nucleosome-reassem-
bly mutations could in principle reflect an additive effect resulting
in growth inhibition due to progressively more impaired
nucleosome reassembly. However, our finding that an Rpd3S
histone-deacetylase mutation, which also activates cryptic promot-
ers [25,71], alleviates the growth defect of spt16-E857K cells that
are also mutant for Bur kinase or Paf1C is more consistent with
models that emphasizes the importance of histone acetylation for
disassembly of a nucleosome encountered by the transcription
elongation complex. Bur kinase, Spt4–Spt5, and Paf1C form a
functional pathway: Bur phosphorylates Spt4–Spt5, which in turn
recruits Paf1C to the transcription complex. Our findings indicate
that this Bur/Spt4–Spt5/Paf1C pathway and FACT have
overlapping nucleosome-related activities that are important for
transcription elongation.
Bur kinase and Spt4–Spt5, which have been independently
implicated genetically in facilitating the transcription of nucleoso-
mal templates [58,67], most likely exert this effect through Paf1C:
yeast Paf1C helps to destabilize nucleosomes upon transcription
induction, and human Paf1C, in cooperation with the histone
acetyltransferase p300, facilitates in vitro transcription elongation
on a chromatin template [63,87]. The disassembly of normally
hypoacetylated nucleosomes is presumably hindered by the
combined effects of spt16-E857K plus a mutation affecting Paf1C
or an upstream pathway component, resulting in impaired
transcription elongation and consequent growth effects. Converse-
ly, Rpd3S deacetylase inactivation, which increases the acetylated
state of nucleosomes [67,71], most likely allows more effective
nucleosome disassembly even when Spt16 and Paf1C are
functionally compromised. This interpretation, coupled with the
findings that spt16-E857K, in Rpd3S-dependent fashion, and the
Bur/Spt4–Spt5/Paf1C pathway have deleterious genetic interac-
tions with the histone chaperone HirC (Figure 5B) [72], supports a
Figure 7. Spt16-E857K mutant protein associates normally with
RNAPII, but poorly with histones. Extracts of cells (strains JS118,
JS119, and JS120) with functional C-terminally S-tagged versions of
Spt16 were treated with S-protein agarose beads, and the bound
material was resolved electrophoretically, blotted, and probed with S-
protein-HRP and with specific antibodies. (A) Spt16 proteins pull down
RNAPII. S-tagged Spt16 and co-purifying material was resolved, blotted,
and probed with antibodies against the RNAPII carboxy-terminal
domain (CTD). (B) Spt16 association with histone H2B is weakened by
the spt16-E857K mutation. S-tagged Spt16 and material co-purifying
from extracts made at different potassium acetate concentrations was
resolved, blotted, and probed with antibodies against H2B. (C) Spt16
proteins do not pull down histone H3. Material was assessed as in (B)
except that antibodies against H3 were used.
doi:10.1371/journal.pone.0025644.g007
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transcription-linked disassembly of Rpd3S-deacetylated nucleo-
somes.
Nucleosome acetylation status is important in spt16-E857K cells,
as indicated not only by the effects of Rpd3S inactivation but also
by the genetic interactions resulting from inactivation or mutation
of the HAT enzymes Gcn5, the acetyltransferase subunit of
SAGA, and Esa1, the acetyltransferase subunit of NuA4. Both
SAGA and NuA4 supply acetyltransferase activity during
transcription elongation [79,80], and both can facilitate the
transcription of a nucleosomal template in vitro [88]. Thus
acetylation is important for transcription-linked nucleosome
disassembly, and becomes even more important in spt16-E857K
cells. The genetic interactions between spt16-E857K and Bur/
Spt4–Spt5/Paf1C pathway mutations suggest that FACT and/or
these elongation factors may mediate transcription-linked nucle-
osome acetylation by the SAGA and/or NuA4 HAT complexes.
A Bur/Spt4–Spt5/Paf1C activity that is unlikely to be involved
in the genetic interactions reported here is the stimulation of Set2
methyltransferase to convert H3K36me2 to H3K36me3. Nucle-
osomal H3K36me2 recruits Rpd3S in vitro and in vivo for the
restoration of chromatin repression; H3K36me3 also binds Rpd3S
in vitro, but its role in vivo is unclear [68,89]. H3K36me3
abundance is significantly decreased by several mutations affecting
Bur kinase and Paf1C [66,90]. In contrast, the spt4D, spt5-4, and
spt5-194 mutations that also have deleterious genetic interactions
with spt16-E857K leave H3K36me3 levels unaffected [25,66].
Therefore, H3K36me3 status is not correlated with deleterious
genetic interactions with spt16-E857K. Similar considerations
dispense with other transcription-related activities that depend
on Paf1C, including histone methylation at H3K4 and H3K36,
and maintenance of CTD Ser-2 phosphorylation levels [62]. We
find that H3K4 methylation is normal in spt16-E857K mutant
cells, the loss of H3K4 methylation or the Ser-2 kinase CTDK-1
fails to impair the growth of these spt16 mutant cells, and the
absence of H3K36 methylation is actually beneficial. Thus the
roles of Paf1C in histone methylation and CTD Ser-2 phosphor-
ylation are unlikely to be involved in the genetic interactions
described here.
An Spt4–Spt5 activity that does have relevance to the genetic
interactions described here is the regulation of Rpd3S localization.
Genome-wide assessment shows that Rpd3S is not uniformly
distributed along transcribed regions [91]. In contrast, in spt4D
cells Rpd3S is more uniformly distributed, matching the
distribution of RNAPII itself. This aberrant distribution may
reflect the association of Rpd3S with the phosphorylated CTD of
RNAPII, a recruitment step that precedes Rpd3S binding to
methylated H3K36 in transcribed nucleosomes [92]. Without
Spt4 to mediate transfer from the CTD to the transcribed
nucleosome, Rpd3S may be ineffective at nucleosomal deacetyla-
tion. A similar situation may be brought about by the spt5-4 and
spt5-194 point mutations used here. The lack of influence of
Rpd3S on the deleterious genetic interactions between spt16-
E857K and Spt4–Spt5 mutations, as found here, may be due to
this aberrant Rpd3S management by the mutant elongation
complex.
Cells relying on Spt16-E857K protein are impaired not only for
transcription-linked nucleosome reassembly [42], but also for the
disassembly of nucleosomes encountered by the transcription
elongation complex, as evidenced by the genetic interactions
described here with factors involved in transcription elongation. In
contrast to the dominant negative effect of mutant FACT
(containing the Spt16-E857K mutant protein) on nucleosome
reassembly, however, the effects of Spt16-E857K on transcription-
linked nucleosome disassembly are recessive, as demanded by the
procedure used here to identify deleterious genetic interactions
between spt16-E857K and mutations inactivating Bur2 and HirC.
Therefore, mutant FACT competes poorly with normal FACT in
the genetic assays of transcription-linked nucleosome disassembly,
even though it competes effectively with normal FACT in the
genetic assays of transcription-linked nucleosome reassembly. One
model to account for this functional difference proposes that
FACT association with the transcription elongation complex is
contingent on nucleosome disassembly, and that the same FACT
complex that associates with an elongation complex as a result of
nucleosome disassembly is retained for reassembly of the same
nucleosome. This model for FACT interactions extends earlier
findings that histone retention during transcription elongation
depends on Spt16 activity [7,20].
The activities of Spt16 for nucleosome reassembly after passage
of the transcription elongation complex and nucleosome disas-
sembly as the transcription elongation complex encounters the
next nucleosome may be genetically separable, as suggested by the
genetic interactions of spt16-E763G, another substitution allele that
impairs nucleosome reassembly. This spt16 mutation did not affect
histone H2B interactions, had no deleterious genetic interactions
with the HirC mutations or histone H2A–H2B overexpression,
caused only mild temperature sensitivity in combination with
bur2D, and showed no interactions with any of the other bur1
mutant alleles (Figures 1C and 7B, and data not shown). This
mutant allele also has a minimal extended phenotype (Table 1).
These genetic distinctions suggest that Spt16-mediated transcrip-
tion-linked nucleosome disassembly is not simply transcription-
linked nucleosome reassembly run in reverse.
More striking spt16 allele differences involve spt16-E857Q,a
substitution mutant allele that relieves the cold sensitivity of a
histone H3 mutation [13]. This mutation, causing a glutamine
substitution at residue 857, fails to activate cryptic promoters and
lacks genetic interactions with bur2D, while spt16-E857K, encoding
a lysine substitution at residue 857, fails to alleviate the cold
sensitivity of the H3 mutation (unpublished observations) [14].
These findings, plus others [14], show that the segment of the
Spt16 protein encompassing residues 857 and 763 has multiple
nucleosome-related activities.
Although almost the entire SPT16 ORF was subjected to
mutagenesis in the identification of the spt16 mutant alleles studied
here and listed in Table 1, the mutations found to have dominant
effects on transcription-linked nucleosome reassembly, including
spt16-E857K and spt16-E763G, alter only a limited segment
approximating the middle domain of the large Spt16 polypeptide
[4]. A bioinformatics approach [93] that predicts whether a
polypeptide sequence has a folded structure resembling any of the
known folds in the PDB protein-structure database indicates, with
very high confidence, that the segment of Spt16 encompassing the
sequence changes in Table 1 adopts the configuration of a double
PH domain. This structural motif comprises two Pleckstrin
Homology (PH) domains, each a 7-strand anti-parallel b-barrel
structure capped at one end by a helix, oriented similarly and
intimately associated with each other. The double PH domain
predicted for Spt16 strongly resembles that determined experi-
mentally for Pob3, the binding partner of Spt16 in yeast FACT
[94]. Thus both components of FACT may contain a double PH
domain. Another protein known to have a double PH domain is
Rtt106, a histone chaperone (like Spt16 and Pob3) that is involved
in transcription [95,96]. Deletion of the gene encoding Rtt106 is
deleterious for cells relying on the Spt16-E857K mutant protein
(unpublished observation), suggesting that these structurally
related proteins have related functions. The segment of Spt16
FACT Involvement in Yeast Transcription Elongation




Strains used in this work are listed in Table S1; all are
derivatives of S288C. Most of the deletion strains used were from
the deletion collection [97]; Paf1C deletions [85,90,98] were a gift
K. Arndt (Univ. of Pittsburgh), and the set1D deletion strain [80]
was from A. Hinnebusch (NIH). The spt4D strain JS34 was
obtained from a cross of strain Y2454 [99] with the BY4741-
derived spt4D::kanMX4 deletion-collection strain, which eliminated
an extra, uncharacterized kanMX4 insertion. All deletion strains
used for direct analysis were confirmed using PCR. Strain
AFO400 was derived by three backcrosses of strain KanB316-
A4HA and derivatives to strain GHY1088, followed by transfor-
mation of an appropriate haploid segregant with pRS314-spt16-
E857K. To create strain bur1D68D3C, one copy of BUR1 was
replaced with a natMX4 cassette in strain KanBd and this
derivative was transformed with pRS316-A4 and pGP161 and
sporulated. Strains JS312 through JS329 are plasmid-shuffle
derivatives in which pGP161 was replaced by versions of BUR1
on pRS315-based plasmids, after which pRS316-A4 was replaced
by versions of SPT16 on pRS314-based plasmids. Before use, esa1-
L254P segregants derived from strain LPY3500 were backcrossed
three times into the Y2454 genetic background. Strains JS337 and
JS338 have rco1D::kanMX4 replaced by rco1D::Ura3MX4 using the
marker-swap plasmid pAG60 [100]. For analysis of rad6D effects,
the rad6D::kanMX4 gene-replacement allele from the BY4741-
derived deletion strain was amplified by PCR and transformed
into Y2454-E857K6BY4741 diploid cells. The resulting spt16-
E857K rad6D heterozygous diploid cells, confirmed using PCR,
were put through meiosis and sporulation, and fresh rad6D single-
mutant and spt16-E857K rad6D double-mutant segregants were
identified at 30uC and analyzed. Standard procedures were used
for cell transformations, PCR, tetrad analysis, plasmid loss, and
plasmid preparation.
Plasmids
The plasmids used in this study are listed in Table S2. pRS314-
and pRS315-based versions of SPT16, spt16-E857K, and spt16-
E763G were created by subcloning from the pRS316-based
versions [42]. S-tagged versions of each of the pRS315-based
plasmids were created by insertion of PCR-amplified DNA
containing S- and His6 tags from pET32, obtained using primers
with XbaI adaptors, into an engineered XbaI site at the 39 end of
the SPT16 ORF. The low-copy LEU2 genomic library p366 was a
gift from B. Andrews (University of Toronto). The low-copy BUR1
TRP1 plasmid pGP161 was a gift from G. Prelich (Albert Einstein
College of Medicine). pRS315-based BUR1 and bur1 mutant
plasmids [49] were gifts from S. Buratowski (Harvard University).
Plasmid pYL102 (HA-tagged H2B) [101] was a gift from R.
Kornberg (Stanford University). Plasmid pAG60 was obtained
from EUROSCARF.
Mutant selection and identification
Plasmid-borne mutant alleles of the SPT16 gene that, in
dominant fashion, bring about transcription from otherwise
repressed ‘cryptic’ promoters were created and selected as
described [42]. DNA sequence obtained for the mutagenized
region of such plasmids, from several independent mutagenesis
runs, often identified a mutation encoding the substitution of
glutamate at position 763 with glycine, which generates the
sought-after phenotype [42]. Mutations causing this E763G
substitution abolish a HindIII restriction site, allowing additional
gap-repaired plasmids with the desired dominant effect to be
screened by restriction analysis. Plasmids lacking a codon-763
mutation harbored a range of dominant mutant alleles, and
fragment-swap plasmid reconstructions were used to eliminate
substitutions with neutral effects. Phenotypes of mutant alleles, on
low-copy pRS316-based plasmids, were assessed in FY2393
(SPT16) and KanB (spt16D) cells. Despite the dominant effect on
reporter-gene expression used for selection, lower-case nomencla-
ture is used here for these novel spt16 mutant alleles because
several phenotypes described below and previously [42] are
recessive.
Synthetic-lethal and library screening
Cells of strain AFO400, chromosomally deleted for SPT16 but
with viability maintained by separate SPT16 and spt16-E857K
plasmids, were subjected to UV mutagenesis, grown at 30uC, and
screened for red/white colony sectoring as described [46,47].
Approximately 70,000 colonies were screened at 30uC for
derivatives that failed to grow after loss of the SPT16 ADE3
URA3 GAL1pr-CEN4 plasmid pSLCDC68, and thus failed to
produce red/white sectored colonies; galactose growth medium
was used to destabilize pSLCDC68 inheritance [102]. A plasmid-
shuffle procedure ruled out instances in which additional
mutations in the spt16-E857K gene were responsible for the
reliance on pSLCDC68. To identify the chromosomal gene
responsible for the synthetic lethality with spt16-E857K, derivatives
were transformed with the LEU2-based centromeric yeast genomic
library p366 and screened for complementation of the lethal
phenotype as indicated by restoration of colony sectoring.
Plasmid-borne genomic inserts were identified by insert-vector
junction sequencing. Mutated genomic loci were retrieved by gap-
repair [103] and sequenced.
Protein extractions
Mid-log phase cells (2–5610
6 cells/ml) were harvested by
centrifugation (2 min, 3000 rpm) and protein extracts were
obtained by glass-bead lysis in disruption buffer [20 mM Tris-Cl
pH 7.9, 10 mM MgCl2, 1 mM EDTA pH 8.0, 5% glycerol,
0.3 M (NH4)2SO4] containing PMSF (10 ml/ml) and protease
inhibitors (Sigma-Aldrich; 1006protease inhibitor stock: 62.5 mg/
ml antipain, 0.05 mg/ml chymostatin, 2.5 mg/ml leupeptin, and
5 mg/ml pepstatin). For pull-down experiments, cells were washed
once with ddH2O and resuspended in 500 ml of Co-IP Buffer
(50 mM Tris-Cl pH 7.4, 50 to 150 mM KOAc, 5 mM EDTA
pH 8.0, 0.1% Triton X-100, 10% glycerol, 1 mM NaN3)
containing protease inhibitors and PMSF, and protein extracts
were obtained by glass-bead lysis. Protein concentrations were
quantified using the Bradford assay (BioRad) with a bovine serum
albumin (BSA) standard.
Co-purifications
Interactions between Spt16 and Nhp6, a transiently associating
FACT subunit, can be detected in buffers with potassium acetate,
but not with sodium chloride [104]. Therefore, buffers for pull-
down studies contained potassium acetate and had low ionic
strength. For Spt16 pull-downs, 500 mg of protein extract in Co-IP
buffer with the desired salt concentration was added to 200 mlo fa
50% slurry of S-protein agarose beads (Novagen, Madison, WI) in
Co-IP buffer and incubated for 2 h with rotation. S-tagged Spt16
and associated proteins bound to the beads were washed 3 times
with 1 ml Co-IP buffer and eluted in 50 mlo f2 6Laemmli buffer
by incubation for 10 min at 100uC.
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Proteins were resolved by SDS-PAGE and transferred to PVDF
membrane (BioRad). Membranes with associated proteins were
blocked overnight at room temperature in 10% milk (Carnation
non-fat milk powder) or 5% BSA (when using antibodies against
the RNAPII CTD) in 0.1% TBS-T buffer (10 mM Tris-HCl
pH 7.4, 140 mM NaCl, 0.1% Tween 20), and washed 3610 min
in 0.1% TBS-T. Incubation with primary antibodies (in 0.1%
TBS-T) was then carried out as follows: anti-HA (12CA5; Abcam,
Cambridge, MA, or Santa Cruz Biotechnologies, Santa Cruz, CA)
1:2000 in 1% milk, 2 h; anti-H3 (ab1791, Abcam) 1:5000 in 1%
milk, 1.5 h; anti-H3K4triMe (ab8580, Abcam) 1:2000 in 1% milk,
2 h; anti-RNAPII (4H8, ab5408, Abcam) 1:15,000 in 5% BSA,
2 h; and S-protein-HRP (Novagen) 1:2000 in 1% milk, 2 h.
Membranes were then washed 3610 min in 0.1% TBS-T,
followed by incubation with secondary antibodies (in 1% milk,
0.1% TBS-T for 2 h): goat anti-rabbit-HRP (Kirkegaard and
Perry Laboratories, Gaithersburg, MD) at 1:5000 (anti-H3 and
anti-H3K4me3 blots), or goat anti-mouse-HRP (Santa Cruz) at
1:2000 (anti-HA and anti-RNAPII blots). Membranes were then
washed 3610 min in 0.1% TBS-T, and bound antibody was
detected using either the LumiGlo Chemiluminescent (Kirkegaard
and Perry) or Western Lightning Chemiluminescent Reagent Plus
(Perkin Elmer, Waltham, MA) substrate system.
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